ArticleSleep2026
Pediatric SleepNet: a deep learning network for reliable pediatric sleep staging across developmental stages.
Article in Sleep, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
STUDY
objectivesManual sleep staging in pediatric populations is challenging due to developmental variability and limited scoring consistency, especially in infants and toddlers. We developed a multimodal deep learning model for pediatric sleep staging and evaluated its performance across a broad age range and diverse clinical subgroups.
methodsWe trained a U-Net-inspired encoder-decoder model (pediatric SleepNet) using 9-channel input signals: electroencephalography (EEG), electrooculography (EOG), and chin electromyography (EMG) using 35-epoch segments from clinical pediatric polysomnograms (PSGs). Models were trained separately on three age groups (<6 months, 6-12 months, >1 year) using 9150 PSGs, with 2455 PSGs reserved for validation. Evaluation was conducted on 3804 held-out test recordings. Performance was compared with U-Sleep and the Complete Artificial Intelligence Sleep Report (CAISR), and stratified analyses were performed across ages, sexes, and seven ICD-10-based disease categories. External validation was conducted on two independent datasets, CHAT and PATS.
resultspediatric SleepNet achieved robust performance across all age groups, with mean Cohen's Kappa increasing from 0.49 (0-6 months) to 0.72 (>12 years). It significantly outperformed U-Sleep and CAISR across early developmental stages. Three-class staging yielded mean Cohen's Kappa increasing from 0.66 (0-6 months) to 0.79 (>12 years). Sex-based differences were negligible. However, significant reductions in performance were observed in children with epilepsy, Down syndrome, hydrocephalus, and other neurodevelopmental conditions. External validation yielded Kappa values >0.69 comparable to the internal test set.
conclusionspediatric SleepNet demonstrates reliable sleep staging across pediatric development. Its robust performance across age, disease, and external datasets supports its potential for clinical and research use in pediatric sleep medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.